Document
IPR2014-00115, No. 2179 Exhibit - Email from Maria Vignone (P.T.A.B. Dec. 29, 2014)
Cite Document
IPR2014-00115, No. 2179 Exhibit - Email from Maria Vignone (P.T.A.B. Dec. 29, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2073 Exhibit - Email dated Sept 16, 2004 WT02106381 (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2073 Exhibit - Email dated Sept 16, 2004 WT02106381 (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2054 Exhibit - Email dated Aug 19, 2004 WT02130756 and attachment WT02130756 (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2054 Exhibit - Email dated Aug 19, 2004 WT02130756 and attachment WT02130756 (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2114 Exhibit - A Powerful Partner, June, 2007, WT01587097 126 (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2114 Exhibit - A Powerful Partner, June, 2007, WT01587097 126 (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 1039 Exhibit - Notice of Allowability in US Patent Application No 11374,330 (P.T.A.B. May. 20, 2014)
Cite Document
IPR2014-00115, No. 1039 Exhibit - Notice of Allowability in US Patent Application No 11374,330 (P.T.A.B. May. 20, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2079 Exhibit - Lab Notebook No 27786 excerpts (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2079 Exhibit - Lab Notebook No 27786 excerpts (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2162 Exhibit - Supplement to Exhibit 2057 Email dated Aug 18, 2004 with attachments (P.T.A.B. Aug. 12, 2014)
Cite Document
IPR2014-00115, No. 2162 Exhibit - Supplement to Exhibit 2057 Email dated Aug 18, 2004 with attachments (P.T.A.B. Aug. 12, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2121 Exhibit - FDA Task Force on Antimicrobial Resistance Key Recommendations and Report, December 5, 2000 (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2121 Exhibit - FDA Task Force on Antimicrobial Resistance Key Recommendations and Report, December 5, 2000 (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2105 Exhibit - US Patent No 8,198,470 (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2105 Exhibit - US Patent No 8,198,470 (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2032 Exhibit - US Patent No 3,026,248 (P.T.A.B. Jul. 22, 2014)
Cite Document
IPR2014-00115, No. 2032 Exhibit - US Patent No 3,026,248 (P.T.A.B. Jul. 22, 2014)
+ More Snippets
Document
IPR2014-00115, No. 2125 Exhibit - Arlington Medical Research, Cost Considerations and Pathogen Coverage for Antibiotics are the Most Important Factors that Influence Hospital Formulary Dec...
Cite Document
IPR2014-00115, No. 2125 Exhibit - Arlington Medical Research, Cost Considerations and Pathogen Coverage for Antibiotics are the Most Important Factors that Influence Hospital Formulary Decision Markin
+ More Snippets
Document
IPR2014-00115, No. 2078 Exhibit - Lab Notebook No 27787 excerpts (P.T.A.B. Jul. 23, 2014)
Cite Document
IPR2014-00115, No. 2078 Exhibit - Lab Notebook No 27787 excerpts (P.T.A.B. Jul. 23, 2014)
+ More Snippets
Document
IPR2014-00115, No. 1003 Exhibit - CN 1390550 (P.T.A.B. Nov. 1, 2013)
Cite Document
IPR2014-00115, No. 1003 Exhibit - CN 1390550 (P.T.A.B. Nov. 1, 2013)
+ More Snippets
Document
IPR2014-00115, No. 2116 Exhibit - Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review Expediting Availability of New Drugs for Patients with Serious Conditions (P.T.A....
Cite Document
IPR2014-00115, No. 2116 Exhibit - Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review Expediting Availability of New Drugs for Patients with Serious Conditions (P.T.A.B. Jul. 2
+ More Snippets
Document
IPR2014-00115, No. 1072 Exhibit - US Patent 5,399,558 Baker (P.T.A.B. Jan. 14, 2015)
Cite Document
IPR2014-00115, No. 1072 Exhibit - US Patent 5,399,558 Baker (P.T.A.B. Jan. 14, 2015)
+ More Snippets